Clinical Trial Update: Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection [Phase 1]

View source ↗

Summary

Phase 1 safety study of cord blood–derived cytokine-induced killer (CIK) cells in patients with solid tumors after radical resection. The listed diseases includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Cord Blood-derived Cytokine-induced Killer Cells (Cytokine-induced killer cells derived from cord blood)

Snippet

Sponsor: Alliancells-PuRui Biocience Co., Ltd. | Conditions: Hepatocellular Carcinoma, Renal Cell Carcinoma | Phase 1 | Status: UNKNOWN